НовостиBenzingaHC Wainwright & Co. Maintains Neutral on Aardvark Therapeutics, Lowers Price Target to $4 HC Wainwright & Co. Maintains Neutral on Aardvark Therapeutics, Lowers Price Target to $4 Benzinga 2026.10.19 10:56 (GMT+0) Открыть на Benzinga Другие новости